Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
An HIVer's social and economic status can be used to determine how effective antiretroviral treatment will be during initial therapy, according to a study published in the August issue of the Journal of Psychosomatic Research. The effect has even been found among subjects with high rates of drug adherence. Researchers in the study--conducted by a team from Harvard School of Public Health, Massachusetts General Hospital, Stanford University Medical School, and the American Psychological Association--used data from a clinical trial that recruited HIV-positive men and women in the United States and Italy who had not previously taken any anti-HIV medications. The study participants were then treated with combination antiretroviral therapy. Experts have previously suggested that stress and emotional distress predict a faster decline in the immune system cells that can fight HIV's progression. Previous studies have also shown that people at lower socioeconomic positions often report chronic stresses in life. The researchers in this study wanted to examine whether socioeconomic position, based on education level, would influence immune functioning and response to antiretroviral treatments--even if patients adhered to their antiretroviral drugs. The study's authors documented the length of time until a participant first experienced a regimen failure, meaning that the drug combination failed to maintain low HIV levels in the bloodstream or that anti-HIV meds needed to be changed or stopped. The researchers found that participants with lower levels of education reached initial regimen failure faster than participants with a college- or graduate-level degree. However, participants with high levels of 'adherence self-efficacy,' despite lower education levels, experienced a reduction in initial regimen failure by 15% to 17%. Adherence self-efficacy was described as a coping resource that reflected the strength of the patient's belief in the effectiveness of their medication and their ability to adhere to their treatment regimen. The authors suggest that one reason behind this association might be that coping styles are often associated with better immune functioning in individuals with HIV disease. 'These findings support health promotion programs focusing on psychological and behavioral aspects associated with therapeutic regimens,' says Linda Marc, who led the research project while a doctor of science candidate in the department of Society, Human Development, and Health at Harvard School of Public Health.
Recommended Stories for You
From our Sponsors
Most Popular
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Grindr is reminding us why jockstraps are so sexy and iconic
May 02 2025 5:36 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Plus: Featured Video
More Videos
0 seconds of 1 minute, 50 secondsVolume 0%
Press shift question mark to access a list of keyboard shortcuts
Keyboard Shortcuts
Shortcuts Open/Close/ or ?
Play/PauseSPACE
Increase Volume↑
Decrease Volume↓
Seek Forward→
Seek Backward←
Captions On/Offc
Fullscreen/Exit Fullscreenf
Mute/Unmutem
Decrease Caption Size-
Increase Caption Size+ or =
Seek %0-9
Copied
Live
00:00
01:50
01:50
Latest Stories
The Talk: Starting the conversation
9 hours ago
BREAKING: Supreme Court rules to save free access to preventive care, including PrEP
June 27 2025 10:32 AM
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
“I felt like a butterfly”: Niko Flowers on reclaiming life with HIV
July 23 2025 12:22 PM
1985: the year the AIDS crisis finally broke through the silence
June 26 2025 11:24 AM
Trump admin guts $258 million in funding for HIV vaccine research
June 03 2025 3:47 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
Dancer. Healer. Survivor. DéShaun Armbrister is all of the above
July 02 2025 8:23 PM
VIDEO: A man living with HIV discusses his journey to fatherhood
June 10 2025 4:58 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM